News

BC Cancer’s 2025 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.

2025 Emerging Multidisciplinary Research Programs Recipients: 

Dr. Brad Nelson has been named as the Lynda and Murray Farmer Immunotherapy Research Chair. The world-renowned immunotherapy expert from BC Cancer – Victoria is the inaugural chairholder. 

Established through a generous $2 million donation from longtime BC Cancer Foundation supporters Lynda and Murray Farmer, the Chair represents a major milestone for BC Cancer – Victoria and for immunotherapy research in British Columbia. 

Each year, the UBC Faculty of Medicine (FoM) recognizes faculty members who have made exceptional contributions in the areas of education, research and/or service, and who are dedicated to advancing both the Faculty’s values and vision of transforming health for everyone.

Two BC Cancer researchers are recipients of the 2025 UBC FoM Distinguished Achievement Awards in the following categories: 

Congratulations to Dr. Ly Vu for receiving a Journey Award from the Canada Centre for Immigrant Women in STEM. The Journey Awards recognize and honour the journeys of immigrant women in STEMM who exemplify leadership, innovation and community service.

Dr. Vu is a scientist at BC Cancer, professor at UBC, and a Canada Research Chair in RNA biology in hematological malignancies.

Researchers with the Lockwood Lab at BC Cancer examined why certain lung tumours manage to resist treatment over time, and what can be done to reduce resistance.

Congratulations to Dr. Pamela Hoodless for receiving a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). 

Dr. Hoodless, a distinguished researcher and Interim Head, Basic and Translational Research at BC Cancer, will use the grant to support her work in defining cell lineages and plasticity in the developing liver.